PI Industries Ltd has reported a 5.8 per cent increase in net profit at Rs. 508.2 crore for the second quarter ended September 30, 2024 as compared to Rs. 480.5 crore in the corresponding quarter of previous fiscal.  Revenue from operations increased 4.9 per cent to Rs. 2,221 crore against Rs. 2,116.9 crore in the same quarter last fiscal. EBITDA was up 14 per cent to Rs. 628.9 crore in the second quarter of the current financial year over Rs.  551.4 crore in the year-ago period.

The EBITDA margin stood at 28.3% in the reporting quarter compared to 26.1% Q2 of FY24.

For the Half Year ended September 30, 2024, PI Industries has reported 11 per cent increase in its net profit at Rs. 957 crore. Revenue from Operation registered a growth of 7 per cent at Rs. 4,289.9 crore. EBITDA was up 18 per cent at Rs. 1,214.2 crore

PI made an offer to acquire Plant Health Care Plc on 26th June 2024. PI completed the acquisition on 20th August 2024 through its wholly subsidiary in Dubai, PI Management Consultancies LLC.

PHC has industry-leading knowledge, products, IP and experience in protein/ peptide technology in the agriculture biological space. PHC technology has gained good traction over the last few years with the registration and commercialisation of its patented PREtec peptide products. Peptides represent next generation of biological crop protection because of high effectiveness and favorable environment profile. In addition to a strong R&D base in the US, PHC products have good acceptance with growers in key markets e.g. the US, Brazil, Europe, and Mexico.